Ignite Creation Date:
2025-12-25 @ 3:28 AM
Ignite Modification Date:
2026-02-08 @ 2:10 PM
Study NCT ID:
NCT03403205
Status:
TERMINATED
Last Update Posted:
2024-06-17
First Post:
2017-12-19
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Efficacy and Safety of ALXN1840 Administered for 48 Weeks Versus Standard of Care in Participants With Wilson Disease
Sponsor:
Alexion Pharmaceuticals, Inc.
Organization: